Interleukin-2: all 213 studies that test it
Page 3 of 3. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.
- Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2CompletedNCT00040586Phase 2
- Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2CompletedNCT00031564Phase 2
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019448Phase 2
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III MelanomaCompletedNCT00004104Phase 2
- Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00003126Phase 3
- Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid TumorsCompletedNCT00002994Phase 1
- A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasCompletedNCT00001564Phase 2
- Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive PatientsCompletedNCT00001474Phase 2
- Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive ChemotherapyCompletedNCT00001440Phase 1
- Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study ModificationsCompletedNCT00001409Phase 1
- Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected PatientsCompletedNCT00001357Phase 2
- Interleukin-2 Therapy for HIV Infection - Supplemental ProceduresCompletedNCT00001354Phase 2
- A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected PatientsCompletedNCT00001282Phase 2